• Home
  • SARS-CoV-2 Process Control (Pellet)
Helix Elite™ Synthetic Standard
Catalog No. R9000

SARS-CoV-2 Process Control (Pellet)

In Stock

kit

In Stock

kit

Details

SARS-CoV-2 Process Control can be used for SARS-CoV-2 assay development, full process control (including extraction), sample adequacy control and spike-in controls. Each kit contains 6 individually packaged lyophilized pellets.
General Information
Documentation

General Information

Biosafety Level1
Product FormatHelix Elite™ Synthetic Standard
Strain CharacteristicsThe SARS-CoV-2 Process Control (Pellet) is made with RNA transcripts containing diagnostically relevant targets (CDC and WHO consensus sequences) encapsulated in a phage protein.

Nucleotides contained in each pellet (All positions in reference to GenBank Acc. NC_045512.2)
• Orf1ab/RdRP: 12,690 ..12,797 | 13,342 ..13,460 | 14,080 ..14,186 | 15,431 ..15,530
• S (Spike): 18,778 ..18,909 | 24,354 ..24,900
• E (Envelope): 26,245 ..26,427 | 26,269 ..26,381
• N (Nucleocapsid): 28,237 ..29,280

Includes human respiratory epithelial cells

RUO
Catalog numberR9000
TaxonomyViruses
Industry TypeClinical

Documents related to this item:

Documentation

Documents related to this item:

Documents related to this product format:

Documentation

Documents related to this product format:

*The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC. Microbiologics, Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures. Look for the ATCC Licensed Derivative © Emblem for products derived from ATCC© cultures.